The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts

Bone

Volumn 60, Issue , 2014, Pages 235-245

  Huang, Su ^a   Eleniste, Pierre P ^a   Wayakanon, Kornchanok ^a   Mandela, Prashant ^b   Eipper, Betty A ^b   Mains, Richard E ^b   Allen, Matthew R ^c   Bruzzaniti, Angela ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GTP exchange factor; Osteoprotegerin, bone remodeling; Receptor activator of nuclear factor b ligand

Indexed keywords

ALKALINE PHOSPHATASE; CELL PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; KALIRIN PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOPROTEGERIN; RHO FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE MASS; BONE MINERALIZATION; BONE REMODELING; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE; GENE FUNCTION; GENE IDENTIFICATION; IN VITRO STUDY; IN VIVO STUDY; KALIRIN GENE; MALE; MOLECULAR DYNAMICS; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

GTP-EXCHANGE FACTOR; OSTEOPROTEGERIN, BONE REMODELING; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR ΚB LIGAND;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; BONE REMODELING; CELL COUNT; CELL DIFFERENTIATION; FEMALE; FEMUR; GENE DELETION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; X-RAY MICROTOMOGRAPHY;

EID: 84892468097     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.12.023     Document Type: Article

References (33)

1. NOF clinician's guide to prevention and treatment of osteoporosis 2012, National osteoporosis foundation, www.nof.org.
2. Bos J.L., Rehmann H., Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007, 129:865-877.
3. Itokowa T., Zhu M.L., Troiano N., Bian J., Kawano T., Insogna K. Osteoclasts lacking Rac2 have defective chemotaxis and resorptive activity. Calcif Tissue Int 2011, 88:75-86.
4. Bourne H.R. ADP-ribosylating toxins and G proteins. Insights into signal transduction 1990, American Society for Microbiology, Washington, DC. J. Moss, M. Vaughan (Eds.).
5. McPherson C.E., Eipper B.A., Mains R.E. Genomic organization and differential expression of Kalirin isoforms. Gene 2002, 284:41-51.
6. McPherson C.E., Eipper B.A., Mains R.E. Kalirin expression is regulated by multiple promoters. J Mol Neurosci 2004, 22:51-62.
7. Penzes P., Johnson R.C., Kambampati V., Mains R.E., Eipper B.A. Distinct roles for the two Rho GDP/GTP exchange factor domains of Kalirin in regulation of neurite growth and neuronal morphology. J Neurosci 2001, 21:8426-8434.
8. Ma X.M., Huang J., Wang Y., Eipper B.A., Mains R.E. Kalirin, a multifunctional Rho guanine nucleotide exchange factor, is necessary for maintenance of hippocampal pyramidal neuron dendrites and dendritic spines. J Neurosci 2003, 23:10593-10603.
9. Ferraro F., Ma X.M., Sobota J.A., Eipper B.A., Mains R.E. Kalirin/Trio Rho guanine nucleotide exchange factors regulate a novel step in secretory granule maturation. Mol Biol Cell 2007, 18:4813-4825.
10. Xie Z., Srivastava D.P., Photowala H., Kai L., Cahill M.E., Woolfrey K.M., et al. Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines. Neuron 2007, 56:640-656.
11. Ma X.M., Kiraly D.D., Gaier E.D., Wang Y., Kim E.J., Levine E.S., et al. Kalirin-7 is required for synaptic structure and function. J Neurosci 2008, 28:12368-12382.
12. Mandela P., Yankova M., Conti L.H., Ma X., Grady J., Eipper B.A., et al. Kalrn plays key roles within and outside of the nervous system. BMC Neurosci 2012, 13:136.
13. Kacena M.A., Eleniste P.P., Cheng Y.H., Huang S., Shivanna M., Meijome T.E., et al. Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts. J Biol Chem 2012, 287:17257-17268.
14. Udagawa N., Takahashi N., Akatsu T., Tanaka H., Sasaki T., Nishihara T., et al. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A 1990, 87:7260-7264.
15. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999, 190:1741-1754.
16. Parfitt A.M., Han Z.H., Palnitkar S., Rao D.S., Shih M.S., Nelson D. Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone. J Bone Miner Res 1997, 12:1864-1873.
17. Mandela P., Ma X.M. Kalirin, a key player in synapse formation, is implicated in human diseases. Neural Plast 2012, 2012:728161.
18. Samoszuk M., Leuther M., Hoyle N. Role of serum P1NP measurement for monitoring treatment response in osteoporosis. Biomark Med 2008, 2:495-508.
19. Glatt V., Canalis E., Stadmeyer L., Bouxsein M.L. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 2007, 22:1197-1207.
20. Janckila A.J., Neustadt D.H., Nakasato Y.R., Halleen J.M., Hentunen T., Yam L.T. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clin Chim Acta 2002, 320:49-58.
21. Mandela P., Yankova M., Conti L.H., Ma X.M., Grady J., Eipper B.A., et al. Kalrn plays key roles within and outside of the nervous system. BMC Neurosci 2012, 13:136.
22. Onoe Y., Miyaura C., Ohta H., Nozawa S., Suda T. Expression of estrogen receptor beta in rat bone. Endocrinology 1997, 138:4509-4512.
23. Ma X.M., Wang Y., Ferraro F., Mains R.E., Eipper B.A. Kalirin-7 is an essential component of both shaft and spine excitatory synapses in hippocampal interneurons. J Neurosci 2008, 28:711-724.
24. Driggers P.H., Segars J.H. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol Metab 2002, 13:422-427.
25. Segars J.H., Driggers P.H. Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol Metab 2002, 13:349-354.
26. Gilad L.A., Bresler T., Gnainsky J., Smirnoff P., Schwartz B. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol 2005, 185:577-592.
27. Koons A., Crandall M., An G.C., Shapiro M.B., Kramer S., West M.A. Even ephemeral endotoxin exposure establishes endotoxin tolerance. J Trauma 2008, 64:938-942.
28. Kusumi A., Kusumi T., Miura J., Tateishi T. Passage-affected competitive regulation of osteoprotegerin synthesis and the receptor activator of nuclear factor-kappaB ligand mRNA expression in normal human osteoblasts stimulated by the application of cyclic tensile strain. J Bone Miner Metab 2009, 27:653-662.
29. Grundt A., Grafe I.A., Liegibel U., Sommer U., Nawroth P., Kasperk C. Direct effects of osteoprotegerin on human bone cell metabolism. Biochem Biophys Res Commun 2009, 389:550-555.
30. Tsubaki M., Satou T., Itoh T., Imano M., Yanae M., Kato C., et al. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Mol Cell Endocrinol 2012, 361:219-231.
31. Moriishi T., Fukuyama R., Ito M., Miyazaki T., Maeno T., Kawai Y., et al. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading. PLoS One 2012, 7:e40143.
32. Sims N.A., Dupont S., Krust A., Clement-Lacroix P., Minet D., Resche-Rigon M., et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002, 30:18-25.
33. Wu X., Tu X., Joeng K.S., Hilton M.J., Williams D.A., Long F. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008, 133:340-353.